Youyuan Xu

发表

Recruitment of β-Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells

S. Balk, A. Hollenberg, Shaoyong Chen, 2004 .

Combination of the mTOR Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial

J. Baselga, J. Bendell, I. Braña, 2014, Clinical Cancer Research.

Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1

G. Bubley, S. Balk, Xin Yuan, 2006, Proceedings of the National Academy of Sciences.

Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells

C. Paweletz, Youwei Yan, M. Wiznerowicz, 2010, The Journal of Biological Chemistry.

Reactivation of androgen receptor-regulated TMPRSS2:ERG gene expression in castration-resistant prostate cancer.

S. Balk, Hongyun Wang, C. Cai, 2009, Cancer research.

Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.

Kenneth N Ross, K. Ross, S. Balk, 2006, Cancer research.

Post-transcriptional Increases in Cyclin D Proteins through Mammalian Target of Rapamycin Activation and Androgens Induce Prostate Cancer Cell Proliferation

K. Ross, S. Balk, Shaoyong Chen, 2006 .

Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells.

S. Balk, A. Hollenberg, Shaoyong Chen, 2004, Molecular endocrinology.

Deletion of beta-catenin impairs T cell development.

W. Birchmeier, J. Huelsken, J. Sen, 2003, Nature immunology.

beta-Catenin expression enhances generation of mature thymocytes.

J. Sen, Youyuan Xu, T. Mulroy, 2003, International immunology.

Doxycycline Regulated Induction of AKT in Murine Prostate Drives Proliferation Independently of p27 Cyclin Dependent Kinase Inhibitor Downregulation

S. Balk, Xin Yuan, Hongyun Wang, 2012, PloS one.

Combination of themTOR Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial

S. Cosimo, J. Bendell, B. Haines, 2014 .

Deletion of β-catenin impairs T cell development

W. Birchmeier, J. Huelsken, J. Sen, 2003, Nature Immunology.

CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall

Zenggang Pan, Mingyi Chen, Endi Wang, 2018, Modern Pathology.

β‐Catenin expression enhances generation of mature thymocytes

J. Sen, Youyuan Xu, T. Mulroy, 2003 .

β‐Catenin expression in thymocytes accelerates thymic involution

J. Sen, Youyuan Xu, 2003 .

Beta-catenin expression in thymocytes accelerates thymic involution.

J. Sen, Youyuan Xu, 2003, European journal of immunology.

Recruitment of (cid:1) -Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells

S. Balk, A. Hollenberg, Shaoyong Chen, 2004 .